Brooks toldReutersHealth that, in the past, nine out of ten U.S. men with a prostate cancer diagnosis have chosen aggressive treatment, frequently regretting the long-term side effects.
World Health Organization representative William Aldis toldReuters that the U.N agency would only accept drugs that had been labeled in the language of the recipient country and that were within six months of their expiry date.